Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
8.30
-0.37 (-4.27%)
Mar 24, 2026, 10:37 AM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceuticals
789.00K
144.93M33.22M34.51M28.27M
Pharmaceuticals Growth
-
336.33%-3.74%22.07%-11.94%
Total
789.00K
144.93M33.22M34.51M28.27M
Total Growth
-
336.33%-3.74%22.07%-11.94%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
789.00K
144.93M33.22M34.51M28.27M
United States Growth
-
336.33%-3.74%22.07%-11.94%
Total
789.00K
144.93M33.22M34.51M28.27M
Total Growth
-
336.33%-3.74%22.07%-11.94%
Source: S&P Global Market Intelligence.